Byoung Chul Cho
机构：Yonsei University, National Cancer Center, Yonsei University Health System · ORCID：0000-0002-5562-270X
发表论文 1620 篇 · 总被引 69961 次 · h-index 107
代表论文
- Osimertinib Plus Gefitinib in Patients with EGFR -Mutated Advanced Non-Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD (2026 · Clinical Cancer Research · 被引 1)
- Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study (2026 · Clinical Cancer Research)
- Integrative stratification of response to immunotherapy using host and microbial signatures in patients with advanced non-small cell lung cancer (2026 · Genome Medicine)
- SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer (2026 · Journal of Clinical Oncology)
- Data from First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non–Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study (2026)
- Supplementary Data 1 from First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non–Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study (2026)